ABOS - Acumen Pharmaceuticals, Inc. -  [ ]

Ticker Details
Acumen Pharmaceuticals, Inc.
IPO Date: July 1, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $181.25M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.18 | 3.76%
Avg Daily Range (30 D): $0.11 | 3.91%
Avg Daily Range (90 D): $0.10 | 4.07%
Institutional Daily Volume
Avg Daily Volume: .34M
Avg Daily Volume (30 D): .63M
Avg Daily Volume (90 D): .53M
Trade Size
Avg Trade Size (Sh.): 115
Avg Trade Size (Sh.) (30 D): 92
Avg Trade Size (Sh.) (90 D): 115
Institutional Trades
Total Institutional Trades: 60
Avg Institutional Trade: $2.13M
Avg Institutional Trade (30 D): $1M
Avg Institutional Trade (90 D): $1M
Avg Institutional Trade Volume: .39M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.31M
Avg Closing Trade (30 D): $3.8M
Avg Closing Trade (90 D): $3.8M
Avg Closing Volume: 640.1K
 
News
Mar 19, 2026 @ 8:00 PM
Acumen Pharmaceuticals to Report Fourth Quarter an...
Source: Na
Mar 10, 2026 @ 8:00 PM
Acumen Pharmaceuticals to Participate in the Stife...
Source: Na
Nov 5, 2025 @ 9:00 PM
Acumen Pharmaceuticals to Report Third Quarter 202...
Source: Acumen Pharmaceuticals
Aug 26, 2025 @ 8:00 PM
Acumen Pharmaceuticals to Participate in Upcoming ...
Source: Acumen Pharmaceuticals
Aug 5, 2025 @ 8:00 PM
Acumen Pharmaceuticals to Report Second Quarter 20...
Source: Acumen Pharmaceuticals
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-2 $-.41 $-2
Diluted EPS $-2 $-.41 $-2
Revenue $M $M $M
Gross Profit
Net Income / Loss $-121.34M $-25.14M $-121.34M
Operating Income / Loss $-123.83M $-25.2M $-123.83M
Cost of Revenue
Net Cash Flow $18.36M $7.16M $18.36M
PE Ratio